Co-incubation of Oocytes With Sperm: Defining the Optimal Incubation Time
NCT ID: NCT04627545
Last Updated: 2024-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2020-11-03
2023-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment
NCT02534857
Sperm Micro-swim up Technique; Process and Select in the Same Dish: a Sibling-oocyte-split Design
NCT05113225
Uterine Interstitial Myolisis and Oocytes Retrieval in Single Step: a Pilot Study
NCT07267754
Time Lag for Oocyte Denudation: A Better Choice for ICSI Outcome?!
NCT04185623
Impact of Dry vs Humidified Culture Conditions on Blastocyst Development and Aneuploidy: A Time-lapse Sibling Oocyte Study
NCT07270250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IVF: 2h exposure
Half of a patients' oocytes will be subjected to 2h exposure to sperm
2h exposure to sperm for IVF
Oocytes will only be briefly (2h) exposed to progressive motile sperm for insemination
IVF: overnight exposure
Half of a patients' oocytes will be subjected to overnight incubation with sperm (=usual practice).
overnight exposure to sperm for IVF
Oocytes will be exposed for a longer duration (overnight, 16-20h) to progressive motile sperm for insemination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2h exposure to sperm for IVF
Oocytes will only be briefly (2h) exposed to progressive motile sperm for insemination
overnight exposure to sperm for IVF
Oocytes will be exposed for a longer duration (overnight, 16-20h) to progressive motile sperm for insemination
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sperm concentration before capacitation: \>15 million per ml (WHO) Total motility (PR+NP %): \>40 (WHO) Progressive motility (PR %):\>32 (WHO)
* Sperm concentration after capacitation: \>0.6 million per ml (not WHO defined) Progressive motility (PR %):\>65 (WHO)
* ≥6 COCs assigned to IVF
* BMI ≤35 kg/m2
* Female age 18 to ≤ 43 years
* All ovarian stimulation protocols
* Fresh ejaculates
* Abstinence duration 2-5 days
* Presence or absence of sperm morphology data: as we do not have a diagnostic sperm analysis for all patients, the presence or absence of \>4% normal morphology (WHO) will not be taken into account, even with known low (\<4%) normal morphology
* Couples requesting Preimplantation Genetic Testing for Aneuploidies
* Arab population
Exclusion Criteria
* Presence of \>1 million per ml round cells in the ejaculate
* If a couple's previous cycle was included in the study
* Previous history of fertilization failure or \<50% fertilisation
* Globozoospermia
* PCO according to the Rotterdam criteria
* Progesterone \>1.5 ng/ml on the day of trigger
18 Years
43 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ART Fertility Clinics LLC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neelke De Munck, PhD
Role: PRINCIPAL_INVESTIGATOR
ART Fertility Clinics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ART Fertility Clinics
Abu Dhabi, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-ABU-010-ND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.